📊 Script: IPCALAB 📊 Sector: Pharmaceuticals 📊 Industry: Pharmaceuticals - Indian - Bulk Drugs Key highlights: 💡⚡ 📈 Keep An Eye on Script, it is trading near its resistance level which is 1248 and may give breakout of it. 📈 Script is trading at upper band of BB. 📈 MACD is giving crossover. 📈 Double Moving Averages are also giving crossover. 📈 Right now RSI...
#IPCALAB Stock looks good for another 20-25% move above. A candle close below ₹1100 would trigger me to close the position. 1) There is a bullish pennant forming with measured target of above ₹1400 2) Horizontal previous ATH support - Looks great.
KIRLPNU 660 TGT 800 SL 600 RR > 2.4 Return >21% TF < 6M Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising Prices. Flag pattern breakout. Pennant Pattern Breakout with Bullish Candle. Retest Successful. Higher Highs & Higher Lows. Broken above RESISTANCE levels Trading at SUPPORT levels Earnings are strong. Bullish Wedge Breakout Risk...
Price has a Upward confirmation and a Weekly Demand ENJOY THE RIDE ! ! !
As per my analysis, 707 level was strong resistance of NSE:IPCALAB . Now resistance has been brake and sustained above 707. My idea is to take buy entry at level of 707 with stop loss of 666 (-41 Points Risk). My expected upside target would be 766 (+59) & 966 (+259 Points). It could be jackpot idea. Note: This is my personal analysis, only to learn stock...
#IPCALAB NSE: IPCALAB CMP: 864 TP: 980 SL: 840 TF: <6m RR > ~4.5 times Return > 13% THYROCARE CNXPHARMA LUPIN SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE APOLLOHOSP FORTIS AARTIDRUGS ZYDUSWELL MAXHEALTH BAJAJHCARE Factors: BULLISH WEDGE...
#LALPATHLAB NSE: LALPATHLAB CMP: 2345 TP: 3075 SL: 2100 TF: <6m RR > ~3 times Return > 30% THYROCARE CNXPHARMA LUPIN SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE APOLLOHOSP FORTIS AARTIDRUGS ZYDUSWELL MAXHEALTH BAJAJHCARE Factors: BULLISH...
#BIOCON NSE: BIOCON CMP: 267 TP: 320 SL: 250 TF: <6m RR > 4 times Return > 20% THYROCARE CNXPHARMA LUPIN NSE:CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising...
#VIMTALABS NSE: VIMTALABS CMP: 461 TP: 560 SL: 410 TF: <6m RR > 2 times Return > 22% THYROCARE CNXPHARMA LUPIN NSE:CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising...
IPCALAB forming inverse head & shoulder pattern looking target 1040-1050-1070++ in very short term Keeping on radar IPCALAB 1020 CE
A bullish engulfing candle has been formed on the daily time frame suggesting a good move in the upward direct is very much possible. There is a good consolidation zone being formed and a breach of the zone(resistance) would surely give a good upward movement in this counter. For buying the stock should be trading above the levels of 1069 and on the other hand...
it's good sign price in a range, whenever price breaks upper range, we can see good move.
Add Ipcalab 1900-1850 we seen 2000/2100/2200+ view invalid below 1780 cb sl Note:- All views are education purpose only.
Buy IPCA lab at the CMP with SL 1776 for intraday and SL 1730 for short term and for TGT >1900 MACD cross over TK cross over Huge volume buy
Short Term Cash Buy IPCALAB @1778.00-1780 SL 1744 TGT 1840 TK cross over with MACD buy with good volume
On technical chart IPCALAB look strong and can achieve our target. We are not SEBI registered.
Lol I know Its confusion getting lots of lines but don't worry you can IPCA lab with stop loss 1650. Looks weekly : Shown rejection in weekly Conclusion: in All tie frame It's looking for Short opportunity. Thanks
IPCA will not only survive , but outperforme other stocks. World is falling because of the fear of poor Q1 results. On the other hand , IPCA will have Huge growth in profits. *IPCA LAB RS 36.31 CRS NSE BLOCK TRADE FOR~ 224839 SHARES, AT RS 1615* #IPCALAB - on 30th april